RxAir360 Inc. is committed to maintaining clear, timely, and accurate communication with our shareholders, regulatory agencies, and future investors.
RxAir360 Inc. is a Delaware-based medical technology company pioneering the first vertically oriented, physician-office-based hyperbaric oxygen therapy (HBOT) chamber.
Our patented system enables hospitals, surgical centers, and specialty physicians to deliver advanced oxygen therapy within standard clinical spaces — expanding access, improving patient outcomes, and creating new revenue opportunities for providers.
Legally incorporated in Delaware
Form 211 submitted to FINRA
Rule 15c2-11 compliant
RxAir360 Inc. has submitted its Form 211 to FINRA for review in preparation for quotation on the OTC Markets. During this period, the company will maintain open access to unaudited financial statements and corporate updates in accordance with Rule 15c2-11 disclosure requirements.
Note: These financials are preliminary and unaudited. They are provided for informational purposes only and should not be interpreted as an offer to sell or a solicitation to buy securities. All information is subject to change pending regulatory review and final approval.
This section provides access to company disclosures, financial reports, and other information required for ongoing due diligence and compliance with FINRA and OTC Markets standards.
Balance Sheet, Income Statement, and Statement of Changes in Equity
Download PDFBalance Sheet, Income Statement, and Statement of Changes in Equity
Download PDFBalance Sheet, Income Statement, and Statement of Changes in Equity
Download PDFBalance Sheet, Income Statement, and Statement of Changes in Equity
Download PDFBalance Sheet, Income Statement, and Statement of Changes in Equity
Download PDFRxAir360 is developing next-generation hyperbaric oxygen therapy (HBOT) systems designed to make advanced oxygen care more accessible to physicians and patients worldwide, pending regulatory clearance.
We engage with a selective network of accredited and strategic partners who share our mission of innovation and accessibility in healthcare.
Request Investor InformationFor qualified and accredited investors
Access key financial and governance materials for informational purposes.
Important Notice: These materials are provided for informational purposes only and do not constitute an offer to sell or a solicitation to buy securities. All financial data is unaudited and subject to change. For detailed investment information, please contact our Investor Relations team directly.
Strategic insights, financial analysis, and management perspective on company performance
View MD&AComprehensive breakdown of equity structure, shareholdings, and current ownership distribution
View Cap SummaryRxAir360 has officially partnered with Inspire Access, a 501(c)(3) nonprofit that helps visionary investors make tax-deductible investments in mission-aligned companies.
Through this partnership, angels, family offices, and foundations can now support RxAir360 using Donor-Advised Funds (DAFs) or other philanthropic vehicles—allowing investors to align purpose with profit while amplifying their long-term social impact.
"Looking to invest without tapping further into your venture allocation? We've partnered with Inspire Access to allow existing and prospective angels to invest in RxAir360 using tax-deductible donations or funds from Donor-Advised Funds (DAFs). Through their vehicle, any returns generated via an exit event flow back into your DAF or charitable fund—maximizing your impact and fueling future giving."
For qualified donors and DAFs
Investment process as little as two weeks
Supporting equitable healthcare innovation
Returns recycle into your charitable fund for future giving
Download the guide to philanthropic investment through Inspire Access
Download OverviewLearn how Inspire Access enables philanthropic investment in just a few minutes
Watch on YouTubeRxAir360 Inc. does not provide legal, tax, or investment advice.
Participation through Inspire Access or any philanthropic investment vehicle should be reviewed with your professional advisors.
All philanthropic investments are subject to Inspire Access's independent approval and underwriting process.
Our leadership team and professional partners ensure the highest standards of corporate governance and regulatory compliance.
Founder & Chief Executive Officer
Chief Financial Officer & Secretary
Director
Director
Director, Medical Advisory Board
Director, Chairman of Medical Advisory Board
Dynamic Stock Transfer, Inc.
ArentFox Schiff LLP
Glendale Securities, Inc.
For investor-related questions, financial disclosures, or partnership opportunities, please contact our Investor Relations Department.
The information provided on this page contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations and are subject to risks and uncertainties that could cause actual results to differ materially.
RxAir360 Inc. undertakes no obligation to update or revise forward-looking statements except as required by law. Investors should conduct their own due diligence and consult with financial advisors before making investment decisions.